COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
申请人:SHY Therapeutics LLC
公开号:US20170174699A1
公开(公告)日:2017-06-22
Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
Multimeric mannosides, a process for preparing the same and their uses as a drug
申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
公开号:US10273313B2
公开(公告)日:2019-04-30
The present invention relates to multimeric mannosides, a process for preparing the same and their uses in medicine for treating Escherichia coli infections. Exemplary compounds are:
TXNIP-TRX COMPLEX INHIBITORS AND METHODS OF USING THE SAME
申请人:CITY OF HOPE
公开号:US20200085800A1
公开(公告)日:2020-03-19
Disclosed herein, inter alia, are compounds and methods for inhibiting the thioredoxin-thioredoxin-interacting-protein (TXNIP-TRX) complex.
[EN] COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU CANCER ET DE MALADIES INFLAMMATOIRES
申请人:SHY THERAPEUTICS LLC
公开号:WO2017112777A1
公开(公告)日:2017-06-29
Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are compositions and methods for treating cancer and inflammatory disease.